Senior insider sale
Chief Executive Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$6.02M
221.33K shares
KROEGER CHRISTOPHER A. plans to sell 221.33K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $6.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2025 | Restricted Stock Unit Grant N/A | 56.42K | — |
7/18/2025 | Restricted Stock Unit Grant N/A | 53.34K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 24.22K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 7.67K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 14.85K | — |
| Total | 156.50K | ||
Completed
Units to sell
16.78K
Market value
$635.9K
Units to sell
69.08K
Market value
$2.54M
Units to sell
61.78K
Market value
$2.27M
Planned — Approximate Date
Units to sell
73.69K
Market value
$575.5K
Units
221.33K
Value
$6.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 16.78K | $635.9K | — | Completed |
7/16/2026 | 69.08K | $2.54M | — | Completed |
7/15/2026 | 61.78K | $2.27M | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 73.69K | $575.5K | Nasdaq | Planned |
| Total | 221.33K | $6.02M | ||